Asciminib Archives - Medical Conferences

Excellent phase 3 results for asciminib in chronic myeloid leukaemia

Presented By

Prof. Andreas Hochhaus, Jena University Hospital, Germany

Trial

Phase 3, ASC4FIRST

Conference

EHA 2024

Type

Peer-reviewed article

12 August 2024 14:25

Deep responses with asciminib in CML-CP

Presented By

Prof. Timothy Hughes, University of Adelaide, Australia

Trial

Phase 3, ASCEMBL

Conference

EHA 2023

Type

Peer-reviewed article

2 August 2023 16:41

First-in-class STAMP inhibitor versus bosutinib in resistant or intolerant CML

Presented By

Dr Andreas Hochhaus, Universitätsklinikum Jena, Germany

Trial

Phase 3, ASCEMBL

Conference

ASH 2020

Type

Peer-reviewed article

18 February 2021 08:58

Asciminib monotherapy in Ph+ CML: major molecular responses

Presented By

Prof. Timothy Hughes, University of Adelaide, Australia

Trial

Phase 1

Conference

EHA 2020

Type

Peer-reviewed article

9 September 2020 13:08

Asciminib plus imatinib in patients with heavily pre-treated chronic myeloid leukaemia

Presented By

Prof. Jorge Cortes, University of Texas MD Anderson Cancer Center, USA

Trial

Phase 1

Conference

EHA 2020

Type

Peer-reviewed article

9 August 2019 12:22